genes, thereby conveying a long-distance p53-dependent transcriptional activation [6] . However, to date, the global functional relevance of transcription at enhancers remains largely unclear. Two recent studies tackle this subject and show that eRNAs can either positively or negatively impact the transcriptional regulation of nearby coding genes [7, 8] .
Li and colleagues set out to investigate the DNA binding profile of oestrogen receptor α (ER-α) in human breast cancer cells [7] . By using Global Run-On sequencing (GRO-Seq) on 17β-oestradiol (E2)-treated cells, they observed a correlation between ER-α-bound enhancers, eRNA induction, and oestrogen-upregulated expression of neighboring genes. To investigate whether eRNA production from ER-α-bound enhancer impacts chromatin structure, they applied a three-dimensional DNA selection and ligation (3D-DSL) procedure. Interestingly, they found that E2 treatment intensified the frequency of interactions between enhancers and promoters. Supporting this notion, targeting eRNAs with antisense oligos reduced the number of enhancerpromoter interactions. As several reports have already indicated cohesin as a key component for the formation and stabilization of chromatin structures [9] , the authors performed immunoprecipitation with antibodies against Rad21 (one subunit of the cohesin complex) followed by deep sequencing (ChIPseq). Indeed, a subset of Rad21-binding sites was clearly overlapping with E2-induced eRNA-producing enhancer domains. This suggested an interaction between eRNAs and the cohesin complex, which was then confirmed by RNA immunoprecipitation experiments. Altogether, Li et al. propose that many enhancers produce eRNAs that attract cohesin complexes to stabilize the chromatin structure between enhancers and promoters.
With a similar approach, Lam et al. [8] endeavored to elucidate the molecular mechanisms by which the nuclear receptors Rev-Erb-α and Rev-Erb-β regulate macrophage gene expression. Using ChIP-Seq the authors established genome-wide binding profiles of these two factors. Detailed analysis revealed that the majority of the shared bound regions of Rev-Erb-α and Rev-Erb-β are located more than 1 kb away from any transcription start site (TSS) and mainly at enhancer domains (as defined by specific epigenetic marks). Lam and colleagues carried on with their investigation by performing GRO-Seq in Rev-Erb-α and Rev-Erb-β double knockout macrophages, which revealed that most of Rev-Erb-bound enhancer regions were producing eRNAs. To explore whether Rev-Erbs directly control eRNA production at bound enhancer regions, as a mean to regulate neighboring gene expression, the authors intersected Rev-Erb loss-and gain-of-function GRO-Seq data with Rev-Erb-β binding profile. This analysis revealed an inverse correlation between Rev-Erb-β binding and the levels of eRNAs. Thus, differently from the activating function of ER-α, Rev-Erbs seemed to silence eRNA production in bound enhancers. This effect was to a large extent mediated by recruiting the NCoR-HDAC3 repressive complexes [10] . Altogether, Lam and colleagues pinpointed the ability of Rev-Erb to npg repress macrophage gene expression by downregulating eRNA production at distant and specific enhancer sites. The next important question was whether the production of sequence-specific eRNAs or the transcription at enhancer regions is the cause of transcriptional regulation of target genes. In other words, do eRNAs possess transcriptional enhancement activity? Melo et al. [6] recently demonstrated that eRNAs produced from p53BERs support the activation of gene expression [6] . Both Li et al. [7] and Lam et al. [8] extended these observations to eRNAs regulated by ER-α and Rev-Erbs. Using various reporter constructs, they demonstrate that the production of sequence-specific eRNAs appears to be a prerequisite for the emergence of enhancing activity ( Figure 1) . Thus, both studies not only confirm the role of eRNAs in transcription enhancement, but also pinpoint sequence requirement and suggest impact on chromatin conformation.
However, numerous intriguing questions remain unanswered. First, the properties or rules governing the specificity of action of the eRNAs are still undefined. One enticing idea involves the potential role of eRNA structure in mediating protein recruitment to specific promoter targets to activate transcription. This type of activation was proposed for long intergenic noncoding RNAs (lincRNAs) [11] and might also occur with eRNAs. Alternatively, sequence homology between eRNAs and promoters could dictate the formation of a RNA-DNA hybrid complex at specific targets, leading to the subsequent alteration in chromatin structure and transcription activity at target genes. Additionally, recent studies have demonstrated the role of the mediator protein complex in the transcription activation by non-coding RNAs (e.g., ncRNA-activating) [12] , raising the possibility that eRNAs might also interact with the mediator complex to control transcription activity. This would suggest that despite the different epigenetic features of eRNAs and ncRNA-activating, the mediator may provide a common mechanistic foundation for both types of transcription regulators. Altogether, recent new reports on eRNA production and function reveal novel insights into the understanding of how enhancers work. As eRNAs are targetable, they may present a point of vulnerability, which can be beneficial for enhancer silencing and gene expression regulation in vivo. 
